-+ 0.00%
-+ 0.00%
-+ 0.00%

Abivax Offering Closes At $747.5M As Underwriters Take Full Option; Net Proceeds Estimated At $700.3M To Support Inflammation Drug Pipeline

Benzinga·07/25/2025 06:23:15
Listen to the news

Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)